![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 13, 2007 9:48:02 AM
Monday August 13, 2007 08:55:15 EDT
Ridgeland, MS, AUG 13, 2007 (EventX/Knobias.com via COMTEX News Network) --
By Jay Everitt, jeveritt@knobias.com
Summus Works, Inc. (SMMW) announced the Company has successfully acquired substantially all the assets and business operations of BioPharmetics, Inc. (Pink Sheets:BPMT).
Three subsidiary divisions of BioPharmetics, Inc. provide quality durable medical equipment, diabetic supplies, and health, beauty, and anti-aging products to customer in the U.S., Canada, and over 23 countries throughout the world. The largest -- the pharmaceutical division -- distributes medical equipment and diabetes supplies, and dispenses physician-prescribed medications through its pharmacy partners. Additionally, the division works closely with a dealer network of health care companies and managed care facilities to provide superior pricing and customer support for Medicare, Medi-Cal, Medicaid and private insurance reimbursement programs.
The Biotechnology division is available for clients wanting to manufacture and test potential prescription medications and assist to facilitate the necessary FDA clinical trials in order to gain approval.
The cosmetic division manages the distribution of the TOMA line of cosmetics as well as private label manufacturing for companies seeking to enter the market place with their own formulations and ideas. BioPharmetics, Inc. was founded in 2005 and is headquartered in Sun Valley, CA.
KNOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.
ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.
If your company wishes to participate in the EventX newswire, please contact Knobias: http://www.knobias.com
Knobias.com, LLC
601-978-3399
601-978-3675
info@knobias.com
www.knobias.com/cmtx
Copyright 2004 Knobias.com, LLC, All rights reserved.
Trading Corner
TD AMERITRADE
Public Reply | Private Reply | Keep | Last Read Replies (4) | Next 10 | Previous | Next
Add Board Mark SMMW Report TOS Violation
Search: Subjects Members Public Msgs My Private Msgs iBox Quote/Chart/Ticker
© 2007 InvestorsHub.Com, Inc.
EOCENE SYSTEM DISEASE MANAGEMENT&COMPLIANCE SYSTEM
FOCUSING ON DIABETES MANAGEMENT
INSTEAD OF DIABETES TESTING
READ POST 76465 VERY IMPORTANT POST
ALSO READ POST 76687
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM